In a strategic expansion to meet the increasing global demand for blood-plasma, Freedom Plasma has inaugurated its newest donation center located at 1743 Maysville Avenue in Zanesville, Ohio. This new facility marks the 71st center in the United States under Freedom Plasma, a subsidiary of ImmunoTek Bio Centers, which currently operates across 13 states. The […]
German pharmaceutical giant Boehringer Ingelheim has announced a significant milestone in the treatment of moderate-to-severe chronic plaque psoriasis. Their drug, Cyltezo, a biosimilar to AbbVie’s renowned psoriasis medication Humira (Adalimumab), has demonstrated clinical equivalence in a pivotal phase 3 trial, known as NCT 02850965. The trial successfully met its primary endpoint, which was the proportion […]
In a significant development for ophthalmic care, Regeneron Pharmaceuticals has received approval from the U.S. Food and Drug Administration (FDA) for a supplemental Biologics License Application (sBLA) for EYLEA (aflibercept) Injection. This approval updates the label to include a modified 12-week dosing schedule for patients with wet age-related macular degeneration (wet AMD), providing a flexible […]
Dutch pharmaceutical giant Norgine has inaugurated new offices in Wettenberg, Germany, marking a significant step in its ongoing growth strategy. This move strengthens its commitment to its largest product sales market, where it has been a key player since 1928. The new facility is set to enhance the company’s operations and support services, ensuring the […]